This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rosenberg, N Articles by Witte, O N Search for Related Content PubMed PubMed Citation Articles by Rosenberg, N Articles by Witte, O N

 Previous Article  |  Next Article 

J Virol. 1980 January; 33(1): 340-348

Abelson murine leukemia virus mutants with alterations in the virus-specific P120 molecule.

ABSTRACT

Abelson murine leukemia virus (A-MuLV) is a replication-defective virus that transforms both fibroblasts and hematopoietic cells in vitro. The virus encodes a 120,000-molecular-weight protein (P120) that is composed of Moloney murine leukemia virus-derived gag gene sequences and A-MuLV--specific sequences. This protein is the only A-MuLV--encoded protein that has been detected, and thus P120 is a candidate for the transforming protein of A-MuLV. We now report isolation and characterization of three new A-MuLV isolates that do not synthesize P120 but do produce analogous proteins of larger (160,000 molecular weight) and smaller (100,000 and 90,000 molecular weight) size. All of these A-MuLV isolates transform fibroblasts and lymphoid cells in vitro. Because the different A-MuLV proteins vary in the A-MuLV--specific region of the molecule, these variants may set a maximum limit on the size of the A-MuLV transforming protein.

This article has been cited by other articles:

• Zimmerman, R. S., Rosenberg, N. (2008). Changes in p19Arf Localization Accompany Apoptotic Crisis during Pre-B-Cell Transformation by Abelson Murine Leukemia Virus. J. Virol. 82: 8383-8391 [Abstract] [Full Text]  
• Yi, C.-R., Rosenberg, N. (2007). Gag Influences Transformation by Abelson Murine Leukemia Virus and Suppresses Nuclear Localization of the v-Abl Protein. J. Virol. 81: 9461-9468 [Abstract] [Full Text]  
• Marchlik, E., Kalman, R., Rosenberg, N. (2005). Decreased Virus Population Diversity in p53-Null Mice Infected with Weakly Oncogenic Abelson Virus. J. Virol. 79: 11618-11626 [Abstract] [Full Text]  
• Warren, D., Griffin, D. S., Mainville, C., Rosenberg, N. (2003). The Extreme Carboxyl Terminus of v-Abl Is Required for Lymphoid Cell Transformation by Abelson Virus. J. Virol. 77: 4617-4625 [Abstract] [Full Text]  
• Warren, D., Heilpern, A. J., Berg, K., Rosenberg, N. (2000). The Carboxyl Terminus of v-Abl Protein Can Augment SH2 Domain Function. J. Virol. 74: 4495-4504 [Abstract] [Full Text]  
• Cho, S. K., Webber, T. D., Carlyle, J. R., Nakano, T., Lewis, S. M., Zuniga-Pflucker, J. C. (1999). Functional characterization of B lymphocytes generated in vitro from embryonic stem cells. Proc. Natl. Acad. Sci. USA 96: 9797-9802 [Abstract] [Full Text]  
• Danial, N. N., Losman, J. A., Lu, T., Yip, N., Krishnan, K., Krolewski, J., Goff, S. P., Wang, J. Y. J., Rothman, P. B. (1998). Direct Interaction of Jak1 and v-Abl Is Required for v-Abl-Induced Activation of STATs and Proliferation. Mol. Cell. Biol. 18: 6795-6804 [Abstract] [Full Text]  
• Shi, Y, Alin, K, Goff, S P (1995). Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity.. Genes Dev. 9: 2583-2597 [Abstract]